Suchergebnisse - "Hyperinflammation"

PubPharm (452)

61

Clinical Characteristics and Laboratory Findings in Children with Multisystem Inflammatory Syndrome (MIS-C)-A Retrospective Study of a Tertiary Care Center from Constanta, Romania

enthalten in: Healthcare (Basel, Switzerland) | 2023

von Mihai, C. | Chisnoiu, T. | Balasa, A. | +5

62

SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade

enthalten in: Journal of molecular cell biology | 2023

von Samsudin, F. | Raghuvamsi, P. | Petruk, G. | +6

63

Recovery of systemic hyperinflammation in patients with severe SARS-CoV-2 infection

enthalten in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals | 2023

von Langnau, C. | Janing, H. | Kocaman, H. | +11

64

Insights into the cellular pathophysiology of familial hemophagocytic lymphohistiocytosis

enthalten in: Frontiers in immunology | 2023

von Steen, E. | Nichols, K. | Meyer, L.

65

Effect of Hemadsorption Therapy in Critically Ill Patients with COVID-19 (CYTOCOV-19) : A Prospective Randomized Controlled Pilot Trial

enthalten in: Blood purification | 2023

von Jarczak, D. | Roedl, K. | Fischer, M. | +8

66

Cytokine Storm Syndrome

enthalten in: Annual review of medicine | 2023

von Cron, R. | Goyal, G. | Chatham, W.

67

Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS) : EAACI Position Paper

enthalten in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology | 2023

von Feleszko, W. | Okarska-Napierała, M. | Buddingh, E. | +22

68

High-dose intravenous anakinra treatment is safe and effective in severe and critical COVID-19 patients: a propensity score-matched study in a single center

enthalten in: Inflammopharmacology | 2023

von Bektaş, M. | Yüce, S. | Ay, M. | +3

69

High-dose intravenous anakinra treatment is safe and effective in severe and critical COVID-19 patients: a propensity score-matched study in a single center

enthalten in: Inflammopharmacology | 2023

von Bektaş, M. | Yüce, S. | Ay, M. | +3

70

High-dose intravenous anakinra treatment is safe and effective in severe and critical COVID-19 patients: a propensity score-matched study in a single center

enthalten in: Inflammopharmacology | 2023

von Bektaş, M. | Yüce, S. | Ay, M. | +3